204 related articles for article (PubMed ID: 22689932)
21. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
[TBL] [Abstract][Full Text] [Related]
22. [Advance in the treatment of heart failure in children].
Ma PR; Huang L; Jiang HL
Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):744-6. PubMed ID: 17229375
[No Abstract] [Full Text] [Related]
23. Is monitoring milrinone therapy useful in advanced heart failure?
Vazir A; Leaver N; Lyster H; Alexanian A; Wilton P; Banner NR
Int J Cardiol; 2011 Jun; 149(3):380-1. PubMed ID: 21450357
[No Abstract] [Full Text] [Related]
24. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
Becker H; Sigmund M
Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
[No Abstract] [Full Text] [Related]
25. Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.
Hauptman PJ; Woods D; Prirzker MR
Clin Cardiol; 2002 May; 25(5):247-9. PubMed ID: 12018885
[TBL] [Abstract][Full Text] [Related]
26. Treatment guidelines for heart failure stress multidrug approach.
Morey SS
Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
[No Abstract] [Full Text] [Related]
27. [Progress in therapy for chronic heart failure].
Hori M
Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():111-5. PubMed ID: 11989248
[No Abstract] [Full Text] [Related]
28. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
[TBL] [Abstract][Full Text] [Related]
29. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol.
Khattar RS; Senior R; Soman P; van der Does R; Lahiri A
Am Heart J; 2001 Oct; 142(4):704-13. PubMed ID: 11579363
[TBL] [Abstract][Full Text] [Related]
30. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.
Nieminen MS; Böhm M; Cowie MR; Drexler H; Filippatos GS; Jondeau G; Hasin Y; Lopez-Sendon J; Mebazaa A; Metra M; Rhodes A; Swedberg K; Priori SG; Garcia MA; Blanc JJ; Budaj A; Cowie MR; Dean V; Deckers J; Burgos EF; Lekakis J; Lindahl B; Mazzotta G; Morais J; Oto A; Smiseth OA; Garcia MA; Dickstein K; Albuquerque A; Conthe P; Crespo-Leiro M; Ferrari R; Follath F; Gavazzi A; Janssens U; Komajda M; Morais J; Moreno R; Singer M; Singh S; Tendera M; Thygesen K;
Eur Heart J; 2005 Feb; 26(4):384-416. PubMed ID: 15681577
[No Abstract] [Full Text] [Related]
31. A case of severe diabetes mellitus occurred during management of heart failure with carvedilol and furosemide.
Kobayakawa N; Sawaki D; Otani Y; Sekita G; Fukushima K; Takeuchi H; Aoyagi T
Cardiovasc Drugs Ther; 2003 May; 17(3):295. PubMed ID: 14669748
[No Abstract] [Full Text] [Related]
32. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
33. Isolated left ventricular hypertrabeculation/noncompaction in a Turner mosaic with male phenotype.
Altenberger H; Stöllberger C; Finsterer J
Acta Cardiol; 2009 Feb; 64(1):99-103. PubMed ID: 19317306
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol: the new role of beta blockers in congestive heart failure.
Vanderhoff BT; Ruppel HM; Amsterdam PB
Am Fam Physician; 1998 Nov; 58(7):1627-34, 1641-2. PubMed ID: 9824960
[TBL] [Abstract][Full Text] [Related]
35. Emerging trends in the management of heart failure: Beta blocker therapy.
Sauls JL; Rone T
Nurs Clin North Am; 2005 Mar; 40(1):135-48. PubMed ID: 15733952
[TBL] [Abstract][Full Text] [Related]
36. Using carvedilol to treat heart failure.
Taccetta-Chapnick M
Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
[No Abstract] [Full Text] [Related]
37. Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
Franciosa JA; Massie BM; Lukas MA; Nelson JJ; Lottes S; Abraham WT; Fowler M; Gilbert EM; Greenberg B;
Am Heart J; 2004 Oct; 148(4):718-26. PubMed ID: 15459606
[TBL] [Abstract][Full Text] [Related]
38. [Cardiac insufficiency. Current treatment].
Aumont MC; Castaigne A
Rev Prat; 1988 Feb; 38(5 Suppl):5-11. PubMed ID: 2895497
[No Abstract] [Full Text] [Related]
39. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
de Peuter OR; Lip GY; Souverein PC; Klungel OH; de Boer A; Büller HR; Kamphuisen PW
Eur J Heart Fail; 2011 May; 13(5):489-95. PubMed ID: 21193438
[TBL] [Abstract][Full Text] [Related]
40. Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).
Komajda M; Lutiger B; Madeira H; Thygesen K; Bobbio M; Hildebrandt P; Jaarsma W; Riegger G; Rydén L; Scherhag A; Soler-Soler J; Remme WJ;
Eur J Heart Fail; 2004 Jun; 6(4):467-75. PubMed ID: 15182773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
